1-[(1R,5S)-3-azabicyclo[3.1.0]hexan-6-yl]-3-methyl-3-quinazolin-4-ylbutan-1-one;(1S,5R)-N-[2-(3H-isoindol-1-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-4-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-5-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[2-(7-methyl-1,2-benzoxazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(7-methyl-2H-indazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(8-methylquinazolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide
C123H149N23O8 — CID 158855509
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[(1R,5S)-3-azabicyclo[3.1.0]hexan-6-yl]-3-methyl-3-quinazolin-4-ylbutan-1-one;(1S,5R)-N-[2-(3H-isoindol-1-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-4-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-5-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[2-(7-methyl-1,2-benzoxazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(7-methyl-2H-indazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(8-methylquinazolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide
1-[(1R,5S)-3-azabicyclo[3.1.0]hexan-6-yl]-3-methyl-3-quinazolin-4-ylbutan-1-one;(1S,5R)-N-[2-(3H-isoindol-1-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-4-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-5-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[2-(7-methyl-1,2-benzoxazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(7-methyl-2H-indazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(8-methylquinazolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide (PubChem CID 158855509) has the molecular formula C123H149N23O8 and a molecular weight of 2077.70 g/mol. Its IUPAC name is 1-[(1R,5S)-3-azabicyclo[3.1.0]hexan-6-yl]-3-methyl-3-quinazolin-4-ylbutan-1-one;(1S,5R)-N-[2-(3H-isoindol-1-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-4-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-5-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[2-(7-methyl-1,2-benzoxazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(7-methyl-2H-indazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(8-methylquinazolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide.
Molecular Properties
| Compound Name | 1-[(1R,5S)-3-azabicyclo[3.1.0]hexan-6-yl]-3-methyl-3-quinazolin-4-ylbutan-1-one;(1S,5R)-N-[2-(3H-isoindol-1-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-4-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-5-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[2-(7-methyl-1,2-benzoxazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(7-methyl-2H-indazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(8-methylquinazolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide |
|---|---|
| PubChem CID | 158855509 |
| Molecular Formula | C123H149N23O8 |
| Molecular Weight | 2077.70 g/mol |
| Exact Mass | 2076.20 |
| IUPAC Name | 1-[(1R,5S)-3-azabicyclo[3.1.0]hexan-6-yl]-3-methyl-3-quinazolin-4-ylbutan-1-one;(1S,5R)-N-[2-(3H-isoindol-1-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-4-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-5-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[2-(7-methyl-1,2-benzoxazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(7-methyl-2H-indazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(8-methylquinazolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide |
| SMILES | CC(C)(CC(=O)C1[C@H]2CNC[C@@H]12)c1ncnc2ccccc12.CC(C)(NC(=O)C1[C@H]2CNC[C@@H]12)C1=NCc2ccccc21.CC(C)(NC(=O)C1[C@H]2CNC[C@@H]12)c1cccc2cnccc12.CC(C)(NC(=O)C1[C@H]2CNC[C@@H]12)c1cncc2ccccc12.Cc1cccc2c(C(C)(C)NC(=O)C3[C@H]4CNC[C@@H]34)[nH]nc12.Cc1cccc2c(C(C)(C)NC(=O)C3[C@H]4CNC[C@@H]34)ncnc12.Cc1cccc2c(C(C)(C)NC(=O)C3[C@H]4CNC[C@@H]34)noc12 |
| InChI | InChI=1S/C18H22N4O.3C18H21N3O.C17H22N4O.C17H21N3O2.C17H21N3O/c1-10-5-4-6-11-15(10)20-9-21-16(11)18(2,3)22-17(23)14-12-7-19-8-13(12)14;1-18(2,21-17(22)16-13-9-20-10-14(13)16)15-5-3-4-11-8-19-7-6-12(11)15;1-18(2,7-15(22)16-12-8-19-9-13(12)16)17-11-5-3-4-6-14(11)20-10-21-17;1-18(2,21-17(22)16-13-8-20-9-14(13)16)15-10-19-7-11-5-3-4-6-12(11)15;1-9-5-4-6-10-14(9)20-21-15(10)17(2,3)19-16(22)13-11-7-18-8-12(11)13;1-9-5-4-6-10-14(9)22-20-15(10)17(2,3)19-16(21)13-11-7-18-8-12(11)13;1-17(2,15-11-6-4-3-5-10(11)7-19-15)20-16(21)14-12-8-18-9-13(12)14/h4-6,9,12-14,19H,7-8H2,1-3H3,(H,22,23);3-8,13-14,16,20H,9-10H2,1-2H3,(H,21,22);3-6,10,12-13,16,19H,7-9H2,1-2H3;3-7,10,13-14,16,20H,8-9H2,1-2H3,(H,21,22);4-6,11-13,18H,7-8H2,1-3H3,(H,19,22)(H,20,21);4-6,11-13,18H,7-8H2,1-3H3,(H,19,21);3-6,12-14,18H,7-9H2,1-2H3,(H,20,21)/t12-,13+,14?;13-,14+,16?;12-,13+,16?;13-,14+,16?;2*11-,12+,13?;12-,13+,14? |
| InChIKey | IZZOYASEUBERKQ-RCMQPLOWSA-N |
| XLogP | 13.18 |
| TPSA | 420.29 Ų |
| H-Bond Donors | 14 |
| H-Bond Acceptors | 24 |
| Rotatable Bonds | 22 |
| Heavy Atoms | 154 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2077.70 |
| LogP ≤ 5 | 13.18 |
| H-Bond Donors ≤ 5 | 14 |
| H-Bond Acceptors ≤ 10 | 24 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158855509 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.